SCHEMBL5515355

SCHEMBL5515355

CCCCOC(=O)N1CCCC([C@@](O)(CCCNC(C)=O)c2cccc(Cl)c2)C1

nearest known ligand 0.64

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4755229 0.93 REN (0.65) REN
SCHEMBL5515427 0.88 REN (0.65) REN
SCHEMBL1871893 0.88 REN (0.66) REN
SCHEMBL1871894 0.88 REN (0.66) REN
SCHEMBL5509846 0.86 REN (0.69) REN
SCHEMBL5603647 0.86 REN (0.69) REN
SCHEMBL13502922 0.81 REN (0.54) REN
SCHEMBL12631883 0.81 REN (0.56) REN
SCHEMBL968278 0.80 REN (0.68) REN
SCHEMBL968276 0.80 REN (0.68) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807078-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2007-07-18 EP disclosed
WO-2006042150-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2006-04-20 WO disclosed